VANGUARD GROUP INC 13D and 13G filings for DexCom, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | DexCom, Inc. DXCM | VANGUARD GROUP INC | 44,467,151 11.510% | 647,315 (+1.48%) | Filing |
| 2023-02-09 11:16 am Purchase | 2022-12-30 | 13G | DexCom, Inc. DXCM | VANGUARD GROUP INC | 43,819,836 11.340% | 2,178,560 (+5.23%) | Filing |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | DexCom, Inc. DXCM | VANGUARD GROUP INC | 41,641,276 10.740% | 712,296 (+1.74%) | Filing |
| 2021-02-10 10:46 am Sale | 2020-12-31 | 13G | DexCom, Inc. DXCM | VANGUARD GROUP INC | 40,928,980 10.660% | -690,716 (-1.66%) | Filing |
| 2020-06-10 10:24 am Purchase | 2020-05-29 | 13G | DexCom, Inc. DXCM | VANGUARD GROUP INC | 41,619,696 11.270% | 7,750,756 (+22.88%) | Filing |